Working… Menu

The Addition of Metformin to Definitive Radiotherapy in Patients With Stage III NSCLC (RADFORMIN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04170959
Recruitment Status : Terminated (Loss of external funding)
First Posted : November 20, 2019
Last Update Posted : January 15, 2021
Stand Up To Cancer
Information provided by (Responsible Party):, University Hospital, Antwerp

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : January 8, 2021
Actual Study Completion Date : January 8, 2021